We showed that stable expression of NLRC5 in B16 cells induces MHC-I and APM genes, upregulates cell surface MHC-I expression and promotes the processing and presentation of an endogenous tumor antigenic peptide from PMEL-1 (gp100) protein [29]. This evidence concerns the gene ANPEP and neoplasm.